Zobrazeno 1 - 10
of 31
pro vyhledávání: '"Yeşim Aktaş"'
Publikováno v:
Beilstein Journal of Organic Chemistry, Vol 19, Iss 1, Pp 139-157 (2023)
Colorectal cancer (CRC) is the third most diagnosed cancer type globally and ranks second in cancer-related deaths. With the current treatment possibilities, a definitive, safe, and effective treatment approach for CRC has not been presented yet. How
Externí odkaz:
https://doaj.org/article/6e808e2e5b2e4f9a9314afdffb0aff76
Autor:
Merve Çelik Tekeli, Çiğdem Yücel, Sedat Ünal, Gökçe Şeker Karatoprak, Yeşim Aktaş, Erem Bilensoy
Publikováno v:
Proceedings, Vol 1, Iss 10, p 1030 (2017)
Paclitaxel (PTX), cytotoxic agent extracted from Taxus brevifolia has significant antineoplastic activity against breast cancer. Poly d,l-lactide-co-glycolide (PLGA) has been widely used for the preparation of nanoparticles carrying cytotoxic drug ag
Externí odkaz:
https://doaj.org/article/8e00a2ded009499ea19ac8e2eab2a68d
Autor:
Sedat Ünal, Çiğdem Yücel, Merve Çelik Tekeli, Gökçe Şeker Karatoprak, Yeşim Aktaş, Erem Bilensoy
Publikováno v:
Proceedings, Vol 1, Iss 10, p 1036 (2017)
Abstract: Paclitaxel (PTX) is a cytotoxic agent derived from Taxus brevifolia used for lung cancer. Poly d,l-lactide- co-glycolide (PLGA) is an FDA-approved biodegradable polymer used for preparation of nanoparticles carrying cytotoxic drug agents. T
Externí odkaz:
https://doaj.org/article/7bf547dc778a4226a4e8634b3f92a9f0
Publikováno v:
Volume: 46, Issue: 3 1009-1029
Journal of Faculty of Pharmacy of Ankara University
Ankara Üniversitesi Eczacılık Fakültesi Dergisi
Zeitschrift der Fakultät für Pharmazie der Universität Ankara
Revista de la Facultad de Farmacia de la Universidad de Ankara
Journal de la Faculté de Pharmacie de l'Université d'Ankara
Journal of Faculty of Pharmacy of Ankara University
Ankara Üniversitesi Eczacılık Fakültesi Dergisi
Zeitschrift der Fakultät für Pharmazie der Universität Ankara
Revista de la Facultad de Farmacia de la Universidad de Ankara
Journal de la Faculté de Pharmacie de l'Université d'Ankara
Amaç: Günümüzde kanser hala en sık görülen kronik hastalıklar arasında yer almaktadır. Polikaprolakton gibi biyouyumlu ve biyoparçalanır polimerlerle hazırlanan nanopartiküler ilaç taşıyıcı sistemler, düşük çözünürlük ve d
Publikováno v:
Turk J Pharm Sci
Publikováno v:
Drug Delivery with Targeted Nanoparticles ISBN: 9781003164739
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d6889ee6f1748fd5ac553550b7a1b97b
https://doi.org/10.1201/9781003164739-4
https://doi.org/10.1201/9781003164739-4
Autor:
Adem Sahin, Gozde Ultav, Yilmaz Capan, Sedenay Akbas, Ece Tavukcuoglu, Yeşim Aktaş, Gunes Esendagli, Hayrettin Tonbul
© 2021 Elsevier B.V.Breast cancer is the most frequent cancer among women and impacts over two million women each year. Although many different types of anticancer agents are available for breast cancer treatment, doxorubicin is one of the most wide
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a62d1133b9f3466e9547ad51f1d19ee4
https://avesis.erciyes.edu.tr/publication/details/2842cc3e-6934-49f9-a4fd-a81936f966d8/oai
https://avesis.erciyes.edu.tr/publication/details/2842cc3e-6934-49f9-a4fd-a81936f966d8/oai
Autor:
Süleyman Can Öztürk, Elif Bilgiç, Sedat Ünal, Erem Bilensoy, Juan M. Benito, Petek Korkusuz, Yeşim Aktaş, Gunes Esendagli, Hamdullah Yanik
Publikováno v:
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V. 169
Colorectal cancer (CRC) is the third most commonly diagnosed cancer in the world and is the second leading cause of cancer related deaths. New cases are increasingly diagnosed every day, but current therapeutic options are still insufficient for an e
The objective of this study was to prepare a stable self-nanoemulsifying formulation of exendin-4, which is an antidiabetic peptide. As exendin-4 is commercially available only in subcutaneous form, several attempts have been made to discover an effe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8384f14f96d241a6106a1c6727d2bfaf
https://avesis.erciyes.edu.tr/publication/details/e8149cfa-9ec8-411c-b1b3-6cbc9b589b1f/oai
https://avesis.erciyes.edu.tr/publication/details/e8149cfa-9ec8-411c-b1b3-6cbc9b589b1f/oai
The objective of this study is to develop a new self-nanoemulsifying system containing exendin-4 with or without enzyme inhibitor chymostatin and to evaluate the effects of oral administration of exendin-4 and exendin-4/chymostatin loaded self nanoem
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0a430ac1c97dd2b2e84ecf053ac9eb06
https://aperta.ulakbim.gov.tr/record/233606
https://aperta.ulakbim.gov.tr/record/233606